Hill-Rom Holdings Inc (NYSE:HRC) issued its quarterly earnings results on Friday. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.05, Bloomberg Earnings reports. The firm had revenue of $738.30 million for the quarter, compared to analysts’ expectations of $731.10 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.18 EPS. Hill-Rom Holdings updated its Q1 guidance to $0.77-0.79 EPS and its FY18 guidance to $4.22-4.30 EPS.

Hill-Rom Holdings (HRC) opened at $77.50 on Friday. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.76 and a quick ratio of 1.33. The stock has a market capitalization of $5.27 billion, a PE ratio of 21.50, a P/E/G ratio of 1.65 and a beta of 1.19.

COPYRIGHT VIOLATION NOTICE: “Hill-Rom Holdings Inc (HRC) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPS” was first posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/03/hill-rom-holdings-inc-hrc-issues-quarterly-earnings-results-beats-expectations-by-0-04-eps.html.

Several equities analysts recently issued reports on HRC shares. Zacks Investment Research upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a research report on Friday, October 27th. KeyCorp restated a “buy” rating and issued a $82.00 price target on shares of Hill-Rom Holdings in a research report on Tuesday, October 17th. Stifel Nicolaus reiterated a “buy” rating and set a $84.00 target price on shares of Hill-Rom Holdings in a research report on Sunday, July 30th. BidaskClub upgraded Hill-Rom Holdings from a “sell” rating to a “hold” rating in a research report on Sunday, August 6th. Finally, Needham & Company LLC dropped their target price on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research report on Friday, July 28th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $87.29.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $77.48, for a total transaction of $532,287.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,293,993.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60. Following the transaction, the senior vice president now owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.